PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-08-02

Date Title Company
02-Aug-2019 FDA Approves Daiichi Sankyo's TURALIO(TM) (pexidartinib) for the Treatment of Select Patients with TGCT, a Rare and Debilitating Tumor Daiichi Sankyo Company, Limited
02-Aug-2019 FDA approves first therapy for rare joint tumor U.S. Food and Drug Administration
02-Aug-2019 FDA approves first therapy for rare joint tumor U.S. Food and Drug Administration
02-Aug-2019 The “Papageorgiou” General Hospital of Thessaloniki joins Clinerion’s hospital network, consolidating Patient Network Explorer coverage in Greece. Clinerion Ltd
02-Aug-2019 Medicure Q2 2019 Results and Conference Call Dates Medicure Inc.
02-Aug-2019 Almac Group Invites Biopharma Industry Members to Learn About Almac Adapt™ - Just in Time Manufacturing at Complimentary Workshop Almac Group
02-Aug-2019 What Is The Ongoing Demand Scene For PSA Test Market? Wired Release
02-Aug-2019 Recent Study- Scar Dressing Market 2019: Analysis by Application, Type, Top Manufacturers, and Forecast to 2029 Wired Release
02-Aug-2019 Opportunities In Global Adhesive Bandages Market Size With Strategies, Holistic View, And Forecast By 2029 Wired Release
02-Aug-2019 What Will Be The Future Scenario Of Anti-decubitus Foam Mattresses Market? Wired Release
02-Aug-2019 Bayer’s Xarelto® (rivaroxaban) receives positive NICE recommendation for use as an option in preventing atherothrombotic events in adult patients in England with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) Bayer
02-Aug-2019 EUROPEAN PATENT NOTICE OF ALLOWANCE FOR THERAPEUTIC COMPOUND, VAL301 VALIRX PLC
02-Aug-2019 E-THERAPEUTICS EXTENDS RESEARCH COLLABORATION WITH NOVO NORDISK AND SIGNS FIRST AGREEMENT ON ITS NEW “GAINs” FUNCTIONAL GENOMICS TECHNOLOGY e-therapeutics plc
02-Aug-2019 Rewind Therapeutics awarded €2.9 million VLAIO grant to discover and develop novel drug candidates for myelin-related neurological diseases Rewind Therapeutics
02-Aug-2019 Drive for generics sees Korea increasingly attractive to international pharma CPhI Korea
02-Aug-2019 Endo Applauds U.S. District Court Decision that Vasopressin Cannot be Used for Compounding by Outsourcing Facilities Endo International plc
02-Aug-2019 Endo Applauds U.S. District Court Decision that Vasopressin Cannot be Used for Compounding by Outsourcing Facilities Endo International plc
02-Aug-2019 HARTMANN GROUP achieves sales growth of 3.7% in the first half of 2019 PAUL HARTMANN AG
02-Aug-2019 Medios AG achieves sales growth of almost 60 per cent in the first half of 2019, as forecast, and is optimistic for the full year Medios AG
02-Aug-2019 Sysmex Obtains Japanese Manufacturing and Marketing Approval for the First Blood-based RAS Mutation Testing for Colorectal Cancer Sysmex Inostics GmbH